Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8413587 | 0.66 | — | — | |
| SCHEMBL31403412 | 0.65 | MEN1 (0.58) | KMT2AMEN1LMNACYP1A2TDP1 | |
| SCHEMBL29187605 | 0.65 | — | — | |
| SCHEMBL27518510 | 0.65 | KMT2A (0.53) | KMT2AMEN1LMNACYP1A2TDP1 | |
| SCHEMBL6516221 | 0.65 | KMT2A (0.73) | KMT2AMEN1LMNACYP1A2TDP1 | |
| SCHEMBL11447100 | 0.64 | KMT2A (0.56) | KMT2AMEN1LMNACYP1A2TDP1 | |
| SCHEMBL11447038 | 0.64 | NPC1 (0.61) | KMT2AMEN1LMNACYP1A2TDP1 | |
| SCHEMBL27816274 | 0.64 | KMT2A (0.78) | KMT2AMEN1LMNACYP1A2TDP1 | |
| SCHEMBL861674 | 0.64 | SMN1; SMN2 (0.84) | KMT2AMEN1TDP1MAPTALDH1A1 | |
| SCHEMBL6751835 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2065047-A1 | Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein | Board of Regents, The University of Texas System (US) | 2009-06-03 | — | — | EP | disclosed |
| EP-1214940-B1 | Methods of enhancing the therapeutic activity of NSAIDs and compositions of zwitterionic phospholipids useful therein | UNIV TEXAS (US) | 2009-03-11 | — | — | EP | disclosed |
| EP-1214940-A1 | Methods of enhancing the therapeutic activity of NSAIDs and compositions of zwitterionic phospholipids useful therein | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-06-19 | — | — | EP | disclosed |
| EP-0805684-B1 | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDS AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN | UNIV TEXAS (US) | 2002-06-12 | — | — | EP | disclosed |
| US-5955451-A | NONSTEROID ANTIINFLAMMATORY AGENTS COMPLEXED WITH ZWITTERIONS OR PHOSPHOLIPIDS FOR NONIRRITATION OF GASTROINTESTINAL SYSTEMS AND ANTIPYRETICS | THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS | 1999-09-21 | — | — | US | disclosed |
| WO-1998013073-A9 | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDs AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN | — | 1998-08-06 | — | — | WO | disclosed |
| EP-0805684-A4 | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDS AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN | UNIV TEXAS (US) | 1998-08-05 | — | — | EP | disclosed |
| US-5763422-A | Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1998-06-09 | — | — | US | disclosed |
| WO-1998013073-A1 | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDs AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1998-04-02 | — | — | WO | disclosed |
| EP-0805684-A2 | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDS AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-11-12 | — | — | EP | disclosed |
| WO-1996022780-A1 | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDS AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 1996-08-01 | — | — | WO | disclosed |
| US-4528193-A | Inflammation-preventing pharmaceutical composition of oral administration | A. NATTERMAN & CIE. GMBH (DE) | 1985-07-09 | — | — | US | disclosed |
| US-4421747-A | PHOSPHOLIPID AND DERIVATIVE OF PHENYLACETIC OR PHENYLPROPIONIC ACID | A. NATTERMANN & CIE. GMBH (DE) | 1983-12-20 | — | — | US | disclosed |
| US-4378354-A | CONSISTING OF A PHOSPHOLIPID AND SALICYLIC ACID OR DERIVATIVE | A. NATTERMANN & CIE. GMBH (DE) | 1983-03-29 | — | — | US | disclosed |
| US-4369182-A | Inflammation-preventing pharmaceutical composition of oral administration | A. NATTERMANN & CIE GMBH (DE) | 1983-01-18 | — | — | US | disclosed |
| US-4332795-A | INDOLE COMPOUND AND PHOSPHOLIPID | A. NATTERMANN & CIE. GMBH (DE) | 1982-06-01 | — | — | US | disclosed |